53 related articles for article (PubMed ID: 9232323)
1. Advancements in Barrett's esophagus detection: The role of artificial intelligence and its implications.
Massironi S
World J Gastroenterol; 2024 Mar; 30(11):1494-1496. PubMed ID: 38617459
[TBL] [Abstract][Full Text] [Related]
2. Artificial Intelligence-Triaged 3-Dimensional Pathology to Improve Detection of Esophageal Neoplasia While Reducing Pathologist Workloads.
Erion Barner LA; Gao G; Reddi DM; Lan L; Burke W; Mahmood F; Grady WM; Liu JTC
Mod Pathol; 2023 Dec; 36(12):100322. PubMed ID: 37657711
[TBL] [Abstract][Full Text] [Related]
3. TSP-9: A Barrett's Esophagus Biomarker Better Than Pathologists?
Rubenstein JH; Stachler MD
Gastroenterology; 2023 Nov; 165(5):1106-1107. PubMed ID: 37659675
[No Abstract] [Full Text] [Related]
4. UGT2B17 and miR-224 contribute to hormone dependency trends in adenocarcinoma and squamous cell carcinoma of esophagus.
Lian X; Baranova A; Ngo J; Yu G; Cao H
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31164411
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus.
Doak SH; Jenkins GJ; Parry EM; D'Souza FR; Griffiths AP; Toffazal N; Shah V; Baxter JN; Parry JM
Gut; 2003 May; 52(5):623-8. PubMed ID: 12692043
[TBL] [Abstract][Full Text] [Related]
6. Clinical use of p53 in Barrett's esophagus.
Keswani RN; Noffsinger A; Waxman I; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1243-9. PubMed ID: 16835318
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus.
Krishnadath KK; Tilanus HW; van Blankenstein M; Bosman FT; Mulder AH
J Pathol; 1995 Feb; 175(2):175-80. PubMed ID: 7738712
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study.
Klump B; Hsieh CJ; Holzmann K; Borchard F; Gaco V; Greschniok A; Eckardt VF; Bettendorf U; Gregor M; Porschen R
Z Gastroenterol; 1999 Oct; 37(10):1005-11. PubMed ID: 10549095
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
10. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
[TBL] [Abstract][Full Text] [Related]
11. Role of brush cytology in the diagnosis of Barrett's esophagus: an analysis of eight cases.
Padmavathy F; Siddaraju N; Sistla SC
Diagn Cytopathol; 2011 Jan; 39(1):60-4. PubMed ID: 21162095
[TBL] [Abstract][Full Text] [Related]
12. Detection of p53 nuclear protein accumulation in brushings and biopsies of Barrett's esophagus.
Tsai TT; Bongiorno PF; Orringer MB; Beer DG
Cancer Detect Prev; 1997; 21(4):326-31. PubMed ID: 9232323
[TBL] [Abstract][Full Text] [Related]
13. The molecular biology of esophageal adenocarcinoma.
Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
